Cargando…

Platforms, advances, and technical challenges in virus-like particles-based vaccines

Viral infectious diseases threaten human health and global stability. Several vaccine platforms, such as DNA, mRNA, recombinant viral vectors, and virus-like particle-based vaccines have been developed to counter these viral infectious diseases. Virus-like particles (VLP) are considered real, presen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Reeshu, Arora, Kajal, Roy, Sourav Singha, Joseph, Abyson, Rastogi, Ruchir, Arora, Nupur Mehrotra, Kundu, Prabuddha K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947793/ https://www.ncbi.nlm.nih.gov/pubmed/36845125 http://dx.doi.org/10.3389/fimmu.2023.1123805

Ejemplares similares

VLP-ELISA for the Detection of IgG Antibodies against Spike, Envelope, and Membrane Antigens of SARS-CoV-2 in Indian Population
por: Kumar, Dilip, et al.
Publicado: (2023)

PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2
por: Mazumder, Saumyabrata, et al.
Publicado: (2021)

Corrigendum to “PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2”[Heliyon 7 (10) (October 2021) e08124]
por: Mazumder, Saumyabrata, et al.
Publicado: (2021)

Establishment of a three-dimensional triculture model on the novel AXTEX-4D™ platform
por: Baru, Ambica, et al.
Publicado: (2022)

Recapitulating Tumor Microenvironment Using AXTEX-4D(TM) for Accelerating Cancer Research and Drug Screening
por: Baru, Ambica, et al.
Publicado: (2022)

Virus like particles as a platform for cancer vaccine development
por: Ong, Hui Kian, et al.
Publicado: (2017)

Bacterium-like particles derived from probiotics: progress, challenges and prospects
por: Zhou, Xinyao, et al.
Publicado: (2023)

Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1
por: Gao, Yong, et al.
Publicado: (2018)

Virus-like particle vaccines with epitopes from porcine epidemic virus and transmissible gastroenteritis virus incorporated into self-assembling ADDomer platform provide clinical immune responses in piglets
por: Du, Pengfei, et al.
Publicado: (2023)

Multiepitope Dendrimeric Antigen-Silica Particle Composites as Nano-Based Platforms for Specific Recognition of IgEs
por: Gil-Ocaña, Violeta, et al.
Publicado: (2021)

The adjuvant effect of bacterium-like particles depends on the route of administration
por: Sudo, Haruka, et al.
Publicado: (2023)

Extracorporeal photopheresis: Review of technical aspects
por: Arora, Satyam, et al.
Publicado: (2017)

Challenges in the diagnosis of periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome in developing countries—A decade of experience from North India
por: Banday, Aaqib Zaffar, et al.
Publicado: (2022)

Design Concepts of Virus-Like Particle-Based HIV-1 Vaccines
por: Chen, Chun-Wei, et al.
Publicado: (2020)

Polymeric Pathogen-Like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A Virus
por: Kingstad-Bakke, Brock, et al.
Publicado: (2021)

Beyond Host Defense: Deregulation of Drosophila Immunity and Age-Dependent Neurodegeneration
por: Arora, Srishti, et al.
Publicado: (2020)

Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based Vaccines
por: Gomes, Ariane C., et al.
Publicado: (2017)

Activation of NLRP3 Inflammasome by Virus-Like Particles of Human Polyomaviruses in Macrophages
por: Lučiūnaitė, Asta, et al.
Publicado: (2022)

Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2022)

Erratum: Virus-like particles are efficient tools for boosting mRNA-induced antibodies
Publicado: (2023)

Spin alignment measurement of vector mesons produced in high energy collisions
por: Mohanty, Bedangadas, et al.
Publicado: (2021)

Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
por: Yang, Yang, et al.
Publicado: (2022)

Evolution of the CS3APIS and the Interoperability Platform
por: Arora, Ishank
Publicado: (2021)

Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
por: Caldeira, Jerri C., et al.
Publicado: (2020)

Modular vaccine platform based on the norovirus-like particle
por: Lampinen, Vili, et al.
Publicado: (2021)

Virus-like Particle Vaccines and Platforms for Vaccine Development
por: Kheirvari, Milad, et al.
Publicado: (2023)

OVERCOMING TECHNICAL CHALLENGES OF BISPECIFIC AND MULTI-SPECIFIC ANTIBODIES USING NOVEL TECHNOLOGY PLATFORMS
por: Xu, Jianqing, et al.
Publicado: (2023)

TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle Immunization
por: Chang, Xinyue, et al.
Publicado: (2022)

A Hybrid Model for Predicting Pattern Recognition Receptors Using Evolutionary Information
por: Kaur, Dilraj, et al.
Publicado: (2020)

Challenging Times: Challenges Accepted!
por: Arora, Sandeep
Publicado: (2022)

An integrated operations model for supply of relief items under path disruptions
por: Scaria, Abyson, et al.
Publicado: (2023)

Development of ESAT-6 Based Immunosensor for the Detection of Mycobacterium tuberculosis
por: Omar, Rishabh Anand, et al.
Publicado: (2021)

Bacterium-Like Particles for Efficient Immune Stimulation of Existing Vaccines and New Subunit Vaccines in Mucosal Applications
por: Van Braeckel-Budimir, Natalija, et al.
Publicado: (2013)

Protective Immunity Induced by Incorporating Multiple Antigenic Proteins of Toxoplasma gondii Into Influenza Virus-Like Particles
por: Lee, Su-Hwa, et al.
Publicado: (2019)

Immunomodulatory Properties of Bacterium-Like Particles Obtained From Immunobiotic Lactobacilli: Prospects for Their Use as Mucosal Adjuvants
por: Raya Tonetti, Fernanda, et al.
Publicado: (2020)

Suitability of potyviral recombinant virus-like particles bearing a complete food allergen for immunotherapy vaccines
por: Pazos-Castro, Diego, et al.
Publicado: (2022)

Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates
por: Zhou, Fangbin, et al.
Publicado: (2023)

Learning YARN: moving beyond MapReduce : learn resource management and big data processing using YARN
por: Arora, Akhil, et al.
Publicado: (2015)

Regulation of Enteric Infection and Immunity by Dietary Proanthocyanidins
por: Andersen-Civil, Audrey I. S., et al.
Publicado: (2021)

6-Valent Virus-Like Particle-Based Vaccine Induced Potent and Sustained Immunity Against Noroviruses in Mice
por: Hou, Wenli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rvlqaqvo08r8mq08j76bqagmh4